TELLA
tella is a biotechnology company providing dendritic cell vaccine therapy for cancer treatment.
TELLA
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2004-06-24
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tella.jp
Status:
Active
Contact:
+81-3-5937-2111
Total Funding:
474 M JPY
Technology used in webpage:
Domain Not Resolving Euro SPF Google Apps For Business SAKURA Internet GMO Internet DNS
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
International Oncology Services
International oncology is a global cancer care and research services company bringing the very best in cancer care to India
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Stelic Institute & Co.
Stelic Institute & Co. engages in the research and development of clinical therapies for fibrosis and cancer treatment.
Investors List
DBJ Capital
DBJ Capital investment in Venture Round - tella
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - tella
Okamoto Masato
Okamoto Masato investment in Venture Round - tella
Yazaki Yuichiro
Yazaki Yuichiro investment in Venture Round - tella
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - tella
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - tella
Yazaki Yuichiro
Yazaki Yuichiro investment in Seed Round - tella
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2013-10-08 | Healios | tella investment in Venture Round - Healios | 3 B JPY |
Official Site Inspections
http://www.tella.jp
- Host name: 195.112.120.153.static.www7467m.sakura.ne.jp
- IP address: 153.120.112.195
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "tella"
Tella Company Profile 2024: Valuation, Funding
Tella Inc is engaged in research and development of dendritic cell vaccine therapy and other cancer treatments in Japan. It also provides total support services …See details»
tella - Crunchbase Company Profile & Funding
When was the last funding round for tella? tella closed its last funding round on Jan 1, 2011 from a Venture - Series Unknown round. Who are tella 's …See details»
tella Company Profile - Office Locations, Competitors, Revenue ...
May 28, 2021 tella is a company that focuses on the research and development of regenerative and cellular medicine, including dendritic cell vaccine therapy. It is also engaged in the …See details»
再生医療ベンチャー#9 テラ | 再生医療.net
Tella Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Tella Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:TLPO-001. ... www.tella.jp. Subsidiary Company | 2014 | Tokyo-to, Japan | www.tella.jp. …See details»
Company tella, Inc. - MarketScreener.com
Feb 28, 2021 tella, Inc. is a Japan-based company mainly engaged in the provision of techniques and operational knowhow associated with cell medicines, as well as the research …See details»
tella Inc - Company Profile and News - Bloomberg Markets
Company profile page for tella Inc including stock price, company news, executives, board members, and contact informationSee details»
tella Inc. Company Profile | StatInvestor
Tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It also offers technology and know-how to medical institutions such as university hospitals and …See details»
tella - Products, Competitors, Financials, Employees, Headquarters ...
Tella.jp. Overview & Products; Financials; Founded Year 2004. Stage IPO | IPO. Date of IPO 3/1/2009. About tella. tella develops immunology products that seeks to cure and prevent …See details»
Company tella Inc OSAKA EXCHANGE - MarketScreener.com
Feb 28, 2021 tella, Inc. is a Japan-based company mainly engaged in the provision of techniques and operational knowhow associated with cell medicines, as well as the research …See details»
Tella - Overview, News & Similar companies | ZoomInfo.com
Who is Tella. tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendriti c cell vaccine therapy to …See details»
tella, Inc.: Shareholders Board Members Managers and Company …
Tella, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Japan Exchange: 2191 | Japan ExchangeSee details»
tella, Inc.: Governance, Directors and Executives & Committees ...
Find the composition of the Board of Directors of tella, Inc. (Japan Exchange Stock Exchange), the gender parity as well as the age distribution of the insiders. …See details»
tella, Inc. | Shared Research
Address: 7-22-36 Nishishinjuku Shinjuku-Ku, Tokyo 160-0023 Website: https://www.tella.jp Key datesSee details»
Nextsource | Company Profile | Terra Firma Japan
Explore the company profile of Terra Firma Japan (tella.jp) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Tella (company) - Golden
Tella is a biotechnology company developing a dendritic cell vaccine cancer therapy. Overview Structured Data Issues Contributors ActivitySee details»
tella, Inc. - VentureRadar
Similar Companies: DCPrime Netherlands Privately Held DCPrime is dedicated to creating more effective immunotherapy products for the treatment of cancer.. DCprime bv Netherlands …See details»
Bankruptcy of a medical company concerns investors in Japan
Tella, a medical venture company listed on the Tokyo Stock Exchange Standard, announced on the 5th that it received a decision to commence bankruptcy from the Tokyo District Court. …See details»
tella, Cenegenics Begin Clinical Trial of Stem Cell Therapy for …
May 29, 2020 tella Inc. and Cenegenics Japan, which are jointly developing a COVID-19 treatment using allogeneic mesenchymal stem cells, said on May 28 that they have started …See details»